<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Osteoporosis – Fragility Fracture Prevention | One‑Page Algorithm</title>
  <meta name="description" content="Clean, printable one‑page algorithm for rapid primary‑care decision making in osteoporosis fragility fracture prevention." />
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&family=Manrope:wght@600;800&display=swap" rel="stylesheet">
  <style>
    :root {
      --bg: #f7f8fb;          /* soft light background */
      --panel: #ffffff;       /* card/background */
      --ink: #1f2a44;         /* deep slate ink */
      --muted: #5b6783;       /* muted text */
      --brand: #377dff;       /* primary blue */
      --accent: #36b37e;      /* green */
      --amber: #ffb020;       /* amber */
      --rose: #ff5a5f;        /* red */
      --border: #e6eaf2;      /* light border */
      --chip: #eef3ff;        /* light chip bg */
      --radius-xl: 18px;
      --radius-lg: 14px;
      --radius-md: 12px;
      --shadow-1: 0 6px 18px rgba(18, 38, 63, 0.06);
      --shadow-2: 0 14px 38px rgba(18, 38, 63, 0.08);
      --maxw: 1120px;
    }
    html, body { height: 100%; background: var(--bg); }
    body {
      margin: 0; color: var(--ink); font-family: Inter, system-ui, -apple-system, Segoe UI, Roboto, Ubuntu, Cantarell, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif; line-height: 1.4;
    }
    .wrap { max-width: var(--maxw); margin: 0 auto; padding: 28px 22px 64px; }
    header.hero {
      background: linear-gradient(180deg, #fff, #f9fbff); border: 1px solid var(--border); box-shadow: var(--shadow-2);
      padding: 28px; border-radius: var(--radius-xl);
    }
    .title {
      display: flex; align-items: center; gap: 16px; flex-wrap: wrap;
    }
    .title h1 {
      font: 800 28px/1.2 Manrope, Inter, sans-serif; margin: 0; letter-spacing: 0.2px;
    }
    .kicker { color: var(--muted); font-weight: 600; font-size: 13px; letter-spacing: 0.6px; text-transform: uppercase; }
    .actions { display: flex; gap: 10px; flex-wrap: wrap; margin-top: 14px; }
    .btn {
      appearance: none; border: 1px solid var(--border); background: var(--panel); color: var(--ink);
      padding: 10px 14px; border-radius: 12px; font-weight: 600; cursor: pointer; box-shadow: var(--shadow-1);
      display: inline-flex; align-items: center; gap: 10px; transition: transform .08s ease, box-shadow .2s ease, background .2s ease;
    }
    .btn:hover { transform: translateY(-1px); box-shadow: var(--shadow-2); }
    .btn.primary { background: var(--brand); color: #fff; border-color: transparent; }
    .btn.ghost { background: #f6f9ff; }
    .chips { display: flex; gap: 8px; flex-wrap: wrap; margin-top: 10px; }
    .chip { background: var(--chip); color: #2b4a9e; border: 1px solid #dfe8ff; padding: 6px 10px; border-radius: 999px; font-weight: 600; font-size: 12px; }

    .grid {
      display: grid; grid-template-columns: 260px 1fr; gap: 22px; margin-top: 22px;
    }
    @media (max-width: 980px) { .grid { grid-template-columns: 1fr; } }

    .toc { position: sticky; top: 18px; align-self: start; background: var(--panel); border: 1px solid var(--border); border-radius: var(--radius-lg); padding: 18px; box-shadow: var(--shadow-1); }
    .toc h3 { margin: 0 0 10px; font: 700 14px/1 Manrope, Inter, sans-serif; letter-spacing: .2px; }
    .toc a { display: block; padding: 8px 10px; margin: 3px 0; color: var(--muted); text-decoration: none; border-radius: 10px; font-weight: 600; }
    .toc a:hover { background: #f1f5ff; color: #274bbb; }

    .cards { display: grid; grid-template-columns: repeat(12, 1fr); gap: 18px; }
    .card { grid-column: span 12; background: var(--panel); border: 1px solid var(--border); border-radius: var(--radius-lg); padding: 18px 18px 16px; box-shadow: var(--shadow-1); }
    .card h2 { display:flex; align-items:center; gap: 10px; margin: 2px 0 10px; font: 800 18px/1.2 Manrope, Inter, sans-serif; }
    .eyebrow { font-size: 12px; font-weight: 700; letter-spacing: .6px; text-transform: uppercase; color: var(--muted); }

    /* Responsive spans */
    .span-6 { grid-column: span 6; }
    .span-4 { grid-column: span 4; }
    .span-8 { grid-column: span 8; }
    @media (max-width: 980px) { .span-6, .span-4, .span-8 { grid-column: span 12; } }

    /* Lists */
    .list { margin: 6px 0 0 0; padding: 0 0 0 18px; }
    .list li { margin: 7px 0; }
    .note { color: var(--muted); font-size: 13px; margin-top: 6px; }

    /* Badges */
    .badge { display: inline-flex; align-items: center; gap: 8px; padding: 6px 10px; border-radius: 999px; font-weight: 700; font-size: 12px; letter-spacing: .2px; }
    .b-high { background: #ffeff1; color: #9e1e2b; border: 1px solid #ffd9de; }
    .b-intermediate { background: #fff7e8; color: #8a5200; border: 1px solid #ffe4b3; }
    .b-low { background: #ecfff2; color: #1b6a3a; border: 1px solid #c7f1d6; }
    .b-very { background: #eef3ff; color: #274bbb; border: 1px solid #dfe8ff; }

    /* Callouts */
    .callout { border-left: 5px solid var(--brand); background: #f2f7ff; padding: 12px 14px; border-radius: 10px; }

    /* Footer */
    footer { margin-top: 24px; color: var(--muted); font-size: 12px; text-align: center; }

    /* Print styles: squeeze into one clean page */
    @media print {
      :root { --bg: #fff; }
      body { background: #fff; }
      .wrap { padding: 0; }
      .hero { box-shadow: none; }
      .actions, .toc { display: none !important; }
      .grid { display: block; }
      .cards { grid-template-columns: repeat(12, 1fr); gap: 12px; }
      .card { padding: 12px 14px; border-radius: 10px; box-shadow: none; }
      h1 { font-size: 22px !important; }
      .card h2 { font-size: 15px; }
      .list li { margin: 4px 0; }
      footer { margin-top: 10px; }
      @page { size: A4; margin: 10mm; }
    }
  </style>
</head>
<body>
  <div class="wrap">
    <header class="hero">
      <div class="title">
        <svg width="36" height="36" viewBox="0 0 24 24" fill="none" aria-hidden="true">
          <path d="M12 3l8 4.5v9L12 21l-8-4.5v-9L12 3z" stroke="#377dff" stroke-width="1.5" fill="#eef3ff"/>
          <circle cx="12" cy="12" r="2.2" fill="#377dff"/>
        </svg>
        <div>
          <div class="kicker">Primary Care Quick Reference</div>
          <h1>Osteoporosis – Fragility Fracture Prevention<br/><span style="font-weight:600; font-size:16px; color:var(--muted);">One‑Page Decision Algorithm</span></h1>
        </div>
      </div>
      <div class="actions" role="group" aria-label="Quick actions">
        <button class="btn primary" onclick="window.print()" title="Print or save as PDF">
          <svg width="18" height="18" viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M7 8V4h10v4M6 17H5a3 3 0 0 1-3-3v-1a3 3 0 0 1 3-3h14a3 3 0 0 1 3 3v1a3 3 0 0 1-3 3h-1" stroke="#fff" stroke-width="1.7" stroke-linecap="round"/><path d="M7 14h10v6H7z" fill="#fff"/></svg>
          Print / PDF
        </button>
        <button class="btn ghost" onclick="toggleCompact()" id="compactBtn" title="Toggle compact layout to fit on one sheet">Compact Layout</button>
        <div class="chips">
          <span class="chip">Adults (≥18y)</span>
          <span class="chip">CKS‑aligned</span>
          <span class="chip">Updated Apr 2025</span>
        </div>
      </div>
    </header>

    <div class="grid">
      <nav class="toc" aria-label="On this page">
        <h3>Sections</h3>
        <a href="#assess">1. Who to Assess</a>
        <a href="#exclude">2. Exclude Secondary Causes</a>
        <a href="#risk">3. Risk Assessment</a>
        <a href="#interpret">4. Interpret & Stratify</a>
        <a href="#manage">5. Management</a>
        <a href="#follow">6. Follow‑Up</a>
        <a href="#redflags">Red Flags</a>
      </nav>

      <main class="cards" id="content">
        <!-- Section 1 -->
        <section class="card" id="assess">
          <div class="eyebrow">Step 1</div>
          <h2>Identify Who to Assess</h2>
          <ul class="list">
            <li><strong>Assess all</strong>: Women ≥65y; Men ≥75y.</li>
            <li><strong>Assess ≥50y with risk factors</strong>: previous fragility fracture; current/frequent oral corticosteroids; history of falls; family history hip fracture; BMI &lt;18.5; smoking; alcohol &gt;14 units/week; secondary causes (endocrine, malabsorption, RA/other inflammatory arthropathies, CKD, COPD, liver disease, immobility).</li>
            <li><strong>&lt;50y</strong>: assess <em>only</em> if major RFs (steroids; untreated premature menopause; multiple/major fractures). For &lt;40y, assess if high‑dose steroids (≥7.5 mg pred daily for ≥3 mo), previous major osteoporotic fracture, or multiple fragility fractures.</li>
            <li class="note">Consider meds increasing risk: SSRIs, enzyme‑inducing antiepileptics (e.g., carbamazepine), aromatase inhibitors, GnRH agonists, PPIs, thiazolidinediones.</li>
          </ul>
        </section>

        <!-- Section 2 -->
        <section class="card" id="exclude">
          <div class="eyebrow">Step 2</div>
          <h2>Exclude Non‑Osteoporotic & Secondary Causes</h2>
          <div class="callout">
            <strong>Rule out</strong>: metastatic bone disease, multiple myeloma, osteomalacia, Paget’s disease. Evaluate endocrine (premature menopause, hypogonadism, diabetes, hyperthyroidism / Cushing’s / hyperparathyroidism), inflammatory arthropathies, malabsorption (IBD, coeliac, chronic pancreatitis), liver disease, COPD.
          </div>
        </section>

        <!-- Section 3 -->
        <section class="card span-6" id="risk">
          <div class="eyebrow">Step 3</div>
          <h2>Risk Assessment</h2>
          <ul class="list">
            <li>Use <strong>QFracture® (preferred)</strong> or <strong>FRAX®</strong> for 10‑yr risk of hip & major osteoporotic fracture.</li>
            <li><strong>≥10%</strong> (10‑yr risk) → arrange <strong>DXA (spine & hip)</strong>.</li>
            <li>Offer DXA without calculator for: age ≥50 with fragility fracture; &lt;40y with a major RF. Consider treatment with vertebral fracture even before DXA.</li>
            <li>Use DXA if risk near threshold or FRAX® likely underestimates risk (e.g., chronic steroids, high alcohol, heavy smoking, multiple fractures; age &gt;80y may underestimate short‑term risk).</li>
          </ul>
        </section>

        <section class="card span-6" id="interpret">
          <div class="eyebrow">Step 4</div>
          <h2>Interpret & Stratify</h2>
          <ul class="list">
            <li><span class="badge b-high">High risk</span> DXA T‑score ≤ −2.5 <em>or</em> FRAX/QFracture above threshold → <strong>start treatment</strong>.</li>
            <li><span class="badge b-intermediate">Intermediate</span> Risk close to threshold → <strong>DXA</strong>; treat if T ≤ −2.5.</li>
            <li><span class="badge b-low">Low risk</span> Below threshold → no drugs; lifestyle advice; re‑assess in ~5 years.</li>
            <li><span class="badge b-very">Very high risk</span> Recent vertebral # (&lt;2y), ≥2 vertebral #, T ≤ −3.5, high‑dose steroids (≥7.5 mg pred ≥3 mo), multiple RFs or high imminent risk → <strong>refer to osteoporosis specialist</strong> (consider parenteral therapy).</li>
          </ul>
        </section>

        <!-- Section 5 -->
        <section class="card" id="manage">
          <div class="eyebrow">Step 5</div>
          <h2>Management</h2>
          <div class="cards" style="padding:0; box-shadow:none; border:none; background:transparent;">
            <div class="card span-6" style="margin:0;">
              <h3 style="margin:0 0 8px; font:700 15px Manrope, Inter, sans-serif;">First‑line Bone‑Sparing Treatment</h3>
              <ul class="list">
                <li><strong>Oral bisphosphonates</strong> (if no contraindications):
                  <ul class="list">
                    <li>Alendronate 70 mg once weekly <strong>or</strong></li>
                    <li>Risedronate 35 mg once weekly</li>
                    <li>Alternative (if unsuitable): Ibandronate 150 mg monthly</li>
                  </ul>
                </li>
                <li><strong>If oral not tolerated/contraindicated</strong>: refer to specialist – options include Zoledronic acid, Denosumab, Teriparatide, Strontium ranelate, Raloxifene.</li>
              </ul>
              <div class="note">Risedronate weekly is licensed in men; all oral bisphosphonates licensed in postmenopausal women.</div>
            </div>
            <div class="card span-6" style="margin:0;">
              <h3 style="margin:0 0 8px; font:700 15px Manrope, Inter, sans-serif;">Supplementation & Lifestyle</h3>
              <ul class="list">
                <li><strong>Vitamin D</strong>: 10 µg (400 IU) daily if low sunlight; if calcium intake inadequate, add ≥1000 mg/day calcium.</li>
                <li><strong>Elderly housebound / nursing home</strong>: Vit D 20 µg (800 IU) + calcium ≥1000 mg/day.</li>
                <li><strong>HRT</strong>: consider in younger postmenopausal women (also for menopausal symptoms).</li>
                <li><strong>Lifestyle</strong>: regular weight‑bearing & strength exercise; balanced diet; smoking cessation; alcohol within limits; assess & mitigate falls risk.</li>
              </ul>
            </div>
            <div class="card span-12" style="margin:0;">
              <h3 style="margin:0 0 8px; font:700 15px Manrope, Inter, sans-serif;">Bisphosphonate Administration – Key Advice</h3>
              <ul class="list">
                <li>Take on an <strong>empty stomach</strong> with a full glass of water; avoid food/other meds for ≥30 min (see specific risedronate timing options).</li>
                <li>Swallow whole; <strong>remain upright ≥30 min</strong>; avoid bedtime dosing.</li>
                <li>Common early GI effects often improve; separate from calcium/antacids by ≥30 min.</li>
                <li>Dental check ideally before starting; maintain oral hygiene; report jaw pain/swelling (possible osteonecrosis).</li>
                <li>Report new hip/groin/thigh pain (possible atypical femoral fracture).</li>
              </ul>
            </div>
          </div>
        </section>

        <!-- Section 6 -->
        <section class="card" id="follow">
          <div class="eyebrow">Step 6</div>
          <h2>Follow‑Up & Review</h2>
          <ul class="list">
            <li><strong>12–16 weeks</strong>: check tolerance (GI, atypical fracture symptoms).</li>
            <li><strong>12 months</strong>: check adherence.</li>
            <li><strong>5 years on oral bisphosphonate</strong>:
              <ul class="list">
                <li><strong>Continue (≥10 years)</strong> if: age ≥70 at start; prior hip/vertebral fracture; fracture during first 5 years.</li>
                <li><strong>Others</strong>: repeat DXA → if T ≤ −2.5 continue 5 more years; if T > −2.5 consider drug holiday 1.5–3 years.</li>
              </ul>
            </li>
            <li><strong>On oral corticosteroids</strong>: maintain bone protection until steroids stopped; then reassess. If medium/low steroid dose and risk near threshold, reassess at 12–18 months.</li>
            <li>Reassess at any time if new fracture or risk factors change.</li>
            <li>If fracture occurs on therapy: check adherence; exclude secondary causes; consider specialist referral to change treatment.</li>
            <li><strong>Low‑risk pathway</strong>: lifestyle advice; re‑assess in ~5 years.</li>
          </ul>
        </section>

        <!-- Red Flags -->
        <section class="card" id="redflags">
          <div class="eyebrow">Referral</div>
          <h2>Red Flags / Specialist Referral</h2>
          <ul class="list">
            <li>Very high imminent risk (e.g., recent vertebral fracture &lt;2 years, ≥2 vertebral fractures).</li>
            <li>T‑score ≤ −3.5.</li>
            <li>High‑dose glucocorticoids (≥7.5 mg prednisolone daily for ≥3 months).</li>
            <li>Multiple clinical risk factors or fracture while adherent to therapy.</li>
          </ul>
        </section>
      </main>
    </div>

    <footer>
      Designed as a compact, light‑theme clinical aide for rapid consultations. This page is formatted to print cleanly on A4. Use the “Compact Layout” toggle if needed.
    </footer>
  </div>

  <script>
    function toggleCompact(){
      document.body.classList.toggle('compact');
      const btn = document.getElementById('compactBtn');
      if(document.body.classList.contains('compact')){
        btn.textContent = 'Comfort Layout';
      } else { btn.textContent = 'Compact Layout'; }
    }
  </script>
</body>
</html>
